Plasma proteome profiling reveals the therapeutic effects of the PPAR pan-agonist chiglitazar on insulin sensitivity, lipid metabolism, and inflammation in type 2 diabetes
Article in Scientific Reports (January 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Scientific Reports (January 2024)
Article in Journal of Drug Delivery Science and Technology (September 2023)
Book chapter (May 2023)